Skip to main content
. Author manuscript; available in PMC: 2015 Nov 3.
Published in final edited form as: Neuropharmacology. 2013 Jul 26;75:95–105. doi: 10.1016/j.neuropharm.2013.07.007

Table 3.

Summary of analysis of variance results for disulfiram-NBI studies. One-way ANOVA was performed for each phase (I–III).

Measure Analysis of variance effect

Phase I Phase II Phase III



df F p df F p df F p
NAc DA 2,6 0.76 ns 2,6 0.09 ns 2,6 12.05 <0.05
NAc GABA 2,6 0.16 ns 2,6 0.38 ns 2,6   3.29 ns
NAc GLu 2,6 0.40 ns 2,6 0.82 ns 2,6   9.80 <0.05